产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 49562-28-9 |
|---|---|---|---|
| 分子式 | C20H21ClO4 | 纯度 | 98% |
| 分子量 | 360.83 | 货号 | abs47027522 |
| 规格 | 100mg | 供货周期 | 现货 |
| 主要用途 | is a Peroxisome Proliferator Receptor al | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Fenofibrate 49562-28-9
| 产品描述 | |
| 描述 | Fenofibrate is a Peroxisome Proliferator Receptor alpha Agonist. The mechanism of action of fenofibrate is as a Peroxisome Proliferator-activated Receptor alpha Agonist. The chemical classification of fenofibrate is PPAR alpha. |
| 纯度 | 98% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 别名 | fei诺贝特 |
| 外观 | 白色或类白色结晶性粉末 |
| 可溶性/溶解性 | DMSO : 36.1 mg/mL (100 mM) Ethanol : 36.1 mg/mL (100 mM) |
| 生物活性 | |
| 靶点 | Cytochrome P450 |
| In vivo(体内研究) | Daily intake of Fenofibrate at this low dose (10 μg/g/day) inhibits retinal and choroidal neovascularization induced by CYP2C8 overexpression by 29% (P=0.021) and 36% (P=1.2×10−9) respectively. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | CardiovascularLipids / LipoproteinsLipid MetabolismCytochromes MetabolismPathways and ProcessesMetabolic signaling pathwaysDrug metabolism MetabolismPathways and ProcessesMetabolic signaling pathwaysLipid and lipoprotein metabolismLipases MetabolismPathways and ProcessesMitochondrial MetabolismCytochromes NeuroscienceDevelopment NeuroscienceProcesses Signal TransductionMetabolismDrug metabolism Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询